- Home
- NMRA vs ATGL Comparison
NMRA vs ATGL Comparison
Compare NMRA & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- ATGL
- Stock Information
- Founded
- NMRA 2019
- ATGL 2017
- Country
- NMRA United States
- ATGL Hong Kong
- Employees
- NMRA N/A
- ATGL N/A
- Industry
- NMRA
- ATGL
- Sector
- NMRA
- ATGL
- Exchange
- NMRA Nasdaq
- ATGL Nasdaq
- Market Cap
- NMRA 121.0M
- ATGL 407.0M
- IPO Year
- NMRA 2023
- ATGL 2023
- Fundamental
- Price
- NMRA $1.49
- ATGL $23.90
- Analyst Decision
- NMRA Buy
- ATGL
- Analyst Count
- NMRA 8
- ATGL 0
- Target Price
- NMRA $9.29
- ATGL N/A
- AVG Volume (30 Days)
- NMRA 1.8M
- ATGL 3.6K
- Earning Date
- NMRA 08-05-2025
- ATGL 01-01-0001
- Dividend Yield
- NMRA N/A
- ATGL N/A
- EPS Growth
- NMRA N/A
- ATGL N/A
- EPS
- NMRA N/A
- ATGL N/A
- Revenue
- NMRA N/A
- ATGL $1,590,148.00
- Revenue This Year
- NMRA N/A
- ATGL N/A
- Revenue Next Year
- NMRA N/A
- ATGL N/A
- P/E Ratio
- NMRA N/A
- ATGL N/A
- Revenue Growth
- NMRA N/A
- ATGL 42.17
- 52 Week Low
- NMRA $0.61
- ATGL $1.15
- 52 Week High
- NMRA $17.19
- ATGL $57.32
- Technical
- Relative Strength Index (RSI)
- NMRA 78.49
- ATGL 42.60
- Support Level
- NMRA $0.72
- ATGL $20.39
- Resistance Level
- NMRA $1.41
- ATGL $22.25
- Average True Range (ATR)
- NMRA 0.13
- ATGL 0.74
- MACD
- NMRA 0.06
- ATGL 0.20
- Stochastic Oscillator
- NMRA 90.63
- ATGL 36.83
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.